Bird & Bird

Bird & Bird houses a deep bench which handles the full spectrum of issues for its lucrative client base of pharma, medical device, and biotech companies. The group regularly advises on marketing authorisations and EU regulations concerning the use of human tissue and allocation of biological material, with the practice experiencing growth on the digital health front. Practice head Marc Martens is known for his expansive regulatory expertise, with particular emphasis on clinical trials and biobanking; Martens regularly appears before the European Court of Justice in disputes concerning data exclusivity, in addition to advising on the lifecycle of biotech products and advanced therapies. Jean-Christophe Troussel has vast knowledge of both contentious and non-contentious IP and technology related matters, with a strong focus on the monetisation of innovation, research and development (R&D) deals, and enforcement strategies. Paul Hermant exhibits broad experience in handling venture capital financings, securities offerings, and M&A within the life sciences space.